tiprankstipranks
Trending News
More News >
Dermapharm Holding (DE:DMP)
:DMP
Germany Market

Dermapharm Holding SE (DMP) Income Statement

Compare
13 Followers

Dermapharm Holding SE Income Statement

Last quarter (Q4 2024), Dermapharm Holding SE's total revenue was €290.67M, an increase of 8.14% from the same quarter last year. In Q4, Dermapharm Holding SE's net income was €20.51M. See Dermapharm Holding SE’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
€ 1.18B€ 1.14B€ 1.02B€ 942.91M€ 793.83M
Gross Profit
€ 767.07M€ 719.16M€ 660.83M€ 620.69M€ 463.48M
Operating Expenses
€ 550.14M€ 536.27M€ 418.78M€ 333.65M€ 318.21M
Depreciation and Amortization
€ 90.50M€ 104.59M€ 101.18M€ 55.60M€ 49.17M
EBITDA
€ 320.91M€ 265.55M€ 329.81M€ 358.10M€ 186.57M
Operating Income
€ 216.93M€ 182.89M€ 243.69M€ 298.47M€ 136.85M
Other Income/Expenses
€ -44.93M€ -76.90M€ -27.39M€ -5.49M€ -11.57M
Pretax Income
€ 172.00M€ 106.00M€ 216.30M€ 292.98M€ 125.28M
Net Income
€ 113.79M€ 62.37M€ 134.24M€ 209.58M€ 85.83M
Per Share Metrics
Basic EPS
€ 2.11€ 1.16€ 2.49€ 3.89€ 1.59
Diluted EPS
€ 2.11€ 1.16€ 2.49€ 3.89€ 1.59
Weighted Average Shares Outstanding
53.84M 53.84M 53.84M 53.84M 53.84M
Weighted Average Shares Outstanding (Diluted)
53.84M 53.84M 53.84M 53.84M 53.84M
Currency in EUR

Dermapharm Holding SE Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis